Top Story

Female physicians make 'substantially' less than male counterparts

July 22, 2016

Significant salary differences exist between male and female physicians at public medical schools, according to findings published in JAMA Internal Medicine.

This gap persisted after accounting for various factors, such as experience, specialty and age, Anupam B. Jena, MD, PhD, from the department of health care policy at Harvard Medical School, and colleagues reported.

Meeting News CoverageVideo

VIDEO: Charles G. Mullighan, MBBS (Hons), MSc, MD, reviews treatment options, potential of tyrosine kinase inhibitors in ALL

July 22, 2016
In this video with Healio.com, Charles G. Mullighan, MBBS (Hons), MSc, MD, of St. Jude Children’s Research Hospital, provides an overview of several molecularly…

Nearly half of physicians see fewer patients each day due to EHR use

July 22, 2016
Physicians have mixed feelings about electronic health record usage, according to a report published by Physicians Practice. The 2016 Tech Report included an annual…

Researcher finds strong evidence that alcohol causes cancer

July 22, 2016
Strong evidence exists that alcohol consumption causes cancer at seven specific sites in the body, according to a paper published in Addiction. Those sites are…

What cancer screenings are recommended for women?

July 22, 2016
Women have a 37% chance of developing invasive cancer during their lifetime, and a 19% chance of dying of cancer, according to American Cancer Society statistics. Early…
More News Headlines »
CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »

VIDEO: James L. M. Ferrara, MD, DSc, reviews “long-standing problem” of GVHD after allogeneic HSCT

July 14, 2016
More »
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting


Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Current Issues
View the Current Issue
HemOnc Today